Status:
COMPLETED
An fMRI Study Of Brain Response In Patients With Fibromyalgia
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Fibromyalgia
Eligibility:
FEMALE
18-70 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to explore how pregabalin works in patients with fibromyalgia by evaluating brain imaging signals. To find out whether fMRI (functional magnetic resonance imaging) is an e...
Detailed Description
Methodology study
Eligibility Criteria
Inclusion
- Women must have pain due to fibromyalgia
- Fibromyalgia must have been diagnosed at least 6 months prior to be eligible for this study
Exclusion
- Patients with severe depression or other serious illness, who are left-handed, or who are pregnant or nursing are not eligible for this study.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00760474
Start Date
January 1 2009
End Date
March 1 2011
Last Update
January 22 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Ann Arbor, Michigan, United States, 48106
2
Pfizer Investigational Site
Ann Arbor, Michigan, United States, 48109